Fig. 2: Summary figure showing timeline of included sources (n = 80) by year of publication, with key stages and publications in full-field stimulus test (FST) development and voretigene neparvovec (VN) clinical trial progression and approval. | Eye

Fig. 2: Summary figure showing timeline of included sources (n = 80) by year of publication, with key stages and publications in full-field stimulus test (FST) development and voretigene neparvovec (VN) clinical trial progression and approval.

From: Full-field stimulus threshold testing: a scoping review of current practice

Fig. 2

CADTH Canadian Agency for Drugs and Technologies in Health, EMA European Medicines Agency, FDA Food and Drug Administration, TGA Therapeutic Goods Administration.

Back to article page